Opioid Prescribing: Rising to the Challenge

Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally in 2022, and 8720 cases reported in the US in 2025. Author Alison Moskowitz, MD, of Memorial Sloan Kettering Cancer Center joins JAMA Deputy Editor Kristin Walter, MD, MS, to ...  Show more

Suboptimal sleep quality and quantity are associated with higher body mass index and more difficulty losing weight. In this podcast, JAMA Insights author Atul Malhotra, MD, from the University of California, San Diego, discusses evidence regarding sleep and obesity with JAMA Depu ...  Show more

Chronic pain affects 40 to 50 million people nationwide, but treating pain today is a complex issue. This episode is the first in our two-part series that addresses the opioid epidemic. We’ll hear from two physicians who are helping to improve chronic pain care in the era of opio ...  Show more

There have been drastic changes made in the regulation of opioids for medical treatment in the past few decades. However, with advent of fentanyl and carfentanil addiction, overdose-related death continues to increase. In this episode, our guests discuss continued regulation of o ...  Show more

Over the past twenty years, over half a million Americans have died of opioid overdoses.

In this episode, we'll explore how this happened, who is responsible, and ask ourselves whether the USA will ever be able to kick its addiction to prescr ...

In the 1980s and 90s, pharmaceutical companies began to market opioid painkillers aggressively, while actively downplaying their addictive potential. The number of prescriptions skyrocketed, and so did cases of addiction, beginning a crisis that continues today. What makes opioid ...  Show more